{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:09:39Z","timestamp":1791295779421,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T00:00:00Z","timestamp":1318291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s10552-011-9847-z","type":"journal-article","created":{"date-parts":[[2011,10,10]],"date-time":"2011-10-10T14:21:54Z","timestamp":1318256514000},"page":"1709-1720","source":"Crossref","is-referenced-by-count":38,"title":["Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO)"],"prefix":"10.1007","volume":"22","author":[{"given":"Valerie A.","family":"McCormack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayjean J.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren R.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Bickeb\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Rosenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua E.","family":"Muscat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tj\u00f8nneland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Friis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Christiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-mi","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Le Marchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gad","family":"Rennert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedy S.","family":"Rennert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeline S.","family":"Andrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Orlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Boffetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Duell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,11]]},"reference":[{"issue":"12","key":"9847_CR1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN. Int J Cancer 127(12):2893\u20132917","journal-title":"Int J Cancer"},{"issue":"2","key":"9847_CR2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69\u201390","journal-title":"CA Cancer J Clin"},{"issue":"17","key":"9847_CR3","first-page":"3761","volume":"58","author":"T Hida","year":"1998","unstructured":"Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S et al (1998) Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 58(17):3761\u20133764","journal-title":"Cancer Res"},{"issue":"2 Suppl 7","key":"9847_CR4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1053\/j.seminoncol.2004.03.045","volume":"31","author":"AB Sandler","year":"2004","unstructured":"Sandler AB, Dubinett SM (2004) COX-2 inhibition and lung cancer. Semin Oncol 31(2 Suppl 7):45\u201352","journal-title":"Semin Oncol"},{"issue":"10","key":"9847_CR5","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","volume":"348","author":"JA Baron","year":"2003","unstructured":"Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R et al (2003) A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 348(10):891\u2013899","journal-title":"N Engl J Med"},{"issue":"9754","key":"9847_CR6","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","volume":"376","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP et al (2010) Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 376(9754):1741\u20131750","journal-title":"Lancet"},{"issue":"21","key":"9847_CR7","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1056\/NEJMoa067208","volume":"356","author":"AT Chan","year":"2007","unstructured":"Chan AT, Ogino S, Fuchs CS (2007) Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 356(21):2131\u20132142","journal-title":"N Engl J Med"},{"issue":"9759","key":"9847_CR8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","volume":"377","author":"PM Rothwell","year":"2011","unstructured":"Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW (2011) Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 377(9759):31\u201341","journal-title":"Lancet"},{"issue":"3","key":"9847_CR9","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1378\/chest.127.3.748","volume":"127","author":"SA Khuder","year":"2005","unstructured":"Khuder SA, Herial NA, Mutgi AB, Federman DJ (2005) Nonsteroidal antiinflammatory drug use and lung cancer: a metaanalysis. Chest 127(3):748\u2013754","journal-title":"Chest"},{"issue":"4","key":"9847_CR10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/pds.1532","volume":"17","author":"JP Kelly","year":"2008","unstructured":"Kelly JP, Coogan P, Strom BL, Rosenberg L (2008) Lung cancer and regular use of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs 25. Pharmacoepidemiol Drug Saf 17(4):322\u2013327","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"9847_CR11","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1158\/1055-9965.EPI-07-0517","volume":"17","author":"AL Dyke Van","year":"2008","unstructured":"Van Dyke AL, Cote ML, Prysak G, Claeys GB, Wenzlaff AS, Schwartz AG (2008) Regular adult aspirin use decreases the risk of non-small cell lung cancer among women. Cancer Epidemiol Biomarkers Prev 17(1):148\u2013157","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"9847_CR12","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1158\/1055-9965.EPI-08-1110","volume":"18","author":"CG Slatore","year":"2009","unstructured":"Slatore CG, Au DH, Littman AJ, Satia JA, White E (2009) Association of nonsteroidal anti-inflammatory drugs with lung cancer: results from a large cohort study. Cancer Epidemiol Biomarkers Prev 18(4):1203\u20131207","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"9847_CR13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.294.1.47","volume":"294","author":"NR Cook","year":"2005","unstructured":"Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE et al (2005) Low-dose aspirin in the primary prevention of cancer: the women\u2019s health study: a randomized controlled trial. JAMA 294(1):47\u201355","journal-title":"JAMA"},{"issue":"7","key":"9847_CR14","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/ijc.22514","volume":"120","author":"S Hernandez-Diaz","year":"2007","unstructured":"Hernandez-Diaz S, Garcia Rodriguez LA (2007) Nonsteroidal anti-inflammatory drugs and risk of lung cancer. Int J Cancer 120(7):1565\u20131572","journal-title":"Int J Cancer"},{"issue":"9","key":"9847_CR15","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/sj.bjc.6603996","volume":"97","author":"D Feskanich","year":"2007","unstructured":"Feskanich D, Bain C, Chan AT, Pandeya N, Speizer FE, Colditz GA (2007) Aspirin and lung cancer risk in a cohort study of women: dosage duration and latency. Br J Cancer 97(9):1295\u20131299","journal-title":"Br J Cancer"},{"issue":"11","key":"9847_CR16","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1158\/1055-9965.EPI-08-0411","volume":"17","author":"RJ Hung","year":"2008","unstructured":"Hung RJ, Christiani DC, Risch A, Popanda O, Haugen A, Zienolddiny S et al (2008) International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev 17(11):3081\u20133089","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"9847_CR17","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/cncr.11242","volume":"97","author":"JE Muscat","year":"2003","unstructured":"Muscat JE, Chen SQ, Richie JP Jr, Altorki NK, Citron M, Olson S et al (2003) Risk of lung carcinoma among users of nonsteroidal antiinflammatory drugs. Cancer 97(7):1732\u20131736","journal-title":"Cancer"},{"issue":"11","key":"9847_CR18","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1289\/ehp.0900566","volume":"117","author":"JE Heck","year":"2009","unstructured":"Heck JE, Andrew AS, Onega T, Rigas JR, Jackson BP, Karagas MR et al (2009) Lung cancer in a U.S. population with low to moderate arsenic exposure. Environ Health Perspect 117(11):1718\u20131723","journal-title":"Environ Health Perspect"},{"issue":"4","key":"9847_CR19","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/14034940601047986","volume":"35","author":"A Tjonneland","year":"2007","unstructured":"Tjonneland A, Olsen A, Boll K, Stripp C, Christensen J, Engholm G et al (2007) Study design, exposure variables, and socioeconomic determinants of participation in Diet, cancer and health: a population-based prospective cohort study of 57, 053 men and women in Denmark. Scand J Public Health 35(4):432\u2013441","journal-title":"Scand J Public Health"},{"issue":"21","key":"9847_CR20","first-page":"4858","volume":"58","author":"L Le Marchand","year":"1998","unstructured":"Le Marchand L, Sivaraman L, Pierce L, Seifried A, Lum A, Wilkens LR et al (1998) Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 58(21):4858\u20134863","journal-title":"Cancer Res"},{"issue":"4","key":"9847_CR21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/1055-9965.EPI-06-0823","volume":"16","author":"CJ Gallagher","year":"2007","unstructured":"Gallagher CJ, Muscat JE, Hicks AN, Zheng Y, Dyer AM, Chase GA et al (2007) The UDP-glucuronosyltransferase 2B17 gene deletion polymorphism: sex-specific association with urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronidation phenotype and risk for lung cancer. Cancer Epidemiol Biomarkers Prev 16(4):823\u2013828","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"9847_CR22","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s10552-004-1093-1","volume":"15","author":"LI Wang","year":"2004","unstructured":"Wang LI, Giovannucci EL, Hunter D, Neuberg D, Su L, Christiani DC (2004) Dietary intake of Cruciferous vegetables, Glutathione S-transferase (GST) polymorphisms and lung cancer risk in a Caucasian population. Cancer Causes Control 15(10):977\u2013985","journal-title":"Cancer Causes Control"},{"issue":"5","key":"9847_CR23","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1378\/chest.118.5.1470","volume":"118","author":"KS Babu","year":"2000","unstructured":"Babu KS, Salvi SS (2000) Aspirin and asthma. Chest 118(5):1470\u20131476","journal-title":"Chest"},{"issue":"6618","key":"9847_CR24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/bmj.296.6618.313","volume":"296","author":"R Peto","year":"1988","unstructured":"Peto R, Gray R, Collins R, Wheatley K, Hennekens C, Jamrozik K et al (1988) Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) 296(6618):313\u2013316","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"9759","key":"9847_CR25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","volume":"377","author":"PM Rothwell","year":"2011","unstructured":"Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW (2011) Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 377(9759):31\u201341","journal-title":"Lancet"},{"issue":"7","key":"9847_CR26","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/ijc.22514","volume":"120","author":"S Hernandez-Diaz","year":"2007","unstructured":"Hernandez-Diaz S, Garcia Rodriguez LA (2007) Nonsteroidal anti-inflammatory drugs and risk of lung cancer. Int J Cancer 120(7):1565\u20131572","journal-title":"Int J Cancer"},{"issue":"4","key":"9847_CR27","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1158\/1055-9965.EPI-08-1110","volume":"18","author":"CG Slatore","year":"2009","unstructured":"Slatore CG, Au DH, Littman AJ, Satia JA, White E (2009) Association of nonsteroidal anti-inflammatory drugs with lung cancer: results from a large cohort study. Cancer Epidemiol Biomarkers Prev 18(4):1203\u20131207","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"17","key":"9847_CR28","first-page":"3761","volume":"58","author":"T Hida","year":"1998","unstructured":"Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S et al (1998) Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 58(17):3761\u20133764","journal-title":"Cancer Res"},{"issue":"22","key":"9847_CR29","first-page":"4997","volume":"58","author":"H Wolff","year":"1998","unstructured":"Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A (1998) Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 58(22):4997\u20135001","journal-title":"Cancer Res"},{"issue":"6","key":"9847_CR30","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0003-4975(03)00119-X","volume":"75","author":"Y Haga","year":"2003","unstructured":"Haga Y, Hiroshima K, Iyoda A, Shibuya K, Shimamura F, Iizasa T et al (2003) Ki-67 expression and prognosis for smokers with resected stage I non-small cell lung cancer. Ann Thorac Surg 75(6):1727\u20131732","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"9847_CR31","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1158\/1940-6207.CAPR-09-0233","volume":"3","author":"ES Kim","year":"2010","unstructured":"Kim ES, Hong WK, Lee JJ, Mao L, Morice RC, Liu DD et al (2010) Biological activity of celecoxib in the bronchial epithelium of current and former smokers. Cancer Prev Res (Phila) 3(2):148\u2013159","journal-title":"Cancer Prev Res (Phila)"},{"issue":"6","key":"9847_CR32","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1053\/j.seminoncol.2009.10.004","volume":"36","author":"JM Siegfried","year":"2009","unstructured":"Siegfried JM, Hershberger PA, Stabile LP (2009) Estrogen receptor signaling in lung cancer. Semin Oncol 36(6):524\u2013531","journal-title":"Semin Oncol"},{"issue":"4","key":"9847_CR33","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1158\/1055-9965.EPI-08-1110","volume":"18","author":"CG Slatore","year":"2009","unstructured":"Slatore CG, Au DH, Littman AJ, Satia JA, White E (2009) Association of nonsteroidal anti-inflammatory drugs with lung cancer: results from a large cohort study. Cancer Epidemiol Biomarkers Prev 18(4):1203\u20131207","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"9847_CR34","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/sj.bjc.6603996","volume":"97","author":"D Feskanich","year":"2007","unstructured":"Feskanich D, Bain C, Chan AT, Pandeya N, Speizer FE, Colditz GA (2007) Aspirin and lung cancer risk in a cohort study of women: dosage, duration and latency 1. Br J Cancer 97(9):1295\u20131299","journal-title":"Br J Cancer"},{"issue":"1","key":"9847_CR35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.294.1.47","volume":"294","author":"NR Cook","year":"2005","unstructured":"Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE et al (2005) Low-dose aspirin in the primary prevention of cancer: the women\u2019s health study: a randomized controlled trial. JAMA 294(1):47\u201355","journal-title":"JAMA"},{"issue":"1","key":"9847_CR36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1158\/1055-9965.EPI-07-0517","volume":"17","author":"AL Dyke Van","year":"2008","unstructured":"Van Dyke AL, Cote ML, Prysak G, Claeys GB, Wenzlaff AS, Schwartz AG (2008) Regular adult aspirin use decreases the risk of non-small cell lung cancer among women. Cancer Epidemiol Biomarkers Prev 17(1):148\u2013157","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9754","key":"9847_CR37","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","volume":"376","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP et al (2010) Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 376(9754):1741\u20131750","journal-title":"Lancet"},{"key":"9847_CR38","doi-asserted-by":"crossref","unstructured":"Aspirin for the primary prevention of cardiovascular events: recommendation and rationale (2002) Ann Intern Med 136(2):157\u2013160","DOI":"10.7326\/0003-4819-136-2-200201150-00015"},{"issue":"10","key":"9847_CR39","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","volume":"348","author":"JA Baron","year":"2003","unstructured":"Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R et al (2003) A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 348(10):891\u2013899","journal-title":"N Engl J Med"},{"issue":"7257","key":"9847_CR40","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/bmj.321.7257.323","volume":"321","author":"R Peto","year":"2000","unstructured":"Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R (2000) Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 321(7257):323\u2013329","journal-title":"BMJ"},{"issue":"5","key":"9847_CR41","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1470-2045(09)70035-X","volume":"10","author":"J Cuzick","year":"2009","unstructured":"Cuzick J, Otto F, Baron JA, Brown PH, Burn J, Greenwald P et al (2009) Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol 10(5):501\u2013507","journal-title":"Lancet Oncol"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-011-9847-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-011-9847-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-011-9847-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T07:33:54Z","timestamp":1560756834000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-011-9847-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,11]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["9847"],"URL":"https:\/\/doi.org\/10.1007\/s10552-011-9847-z","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,11]]}}}